United States Insulin Pump Market 2017-2022 - Key Companies are Insulet, Medtronic, Roche, Animas & Tandem Diabetes Care - Research and Markets

DUBLIN--()--The "United States Insulin Pump Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022" report has been added to Research and Markets' offering.

The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022.

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.

Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

Key Companies Covered in the Report are as follows:

- Insulet Corporation

- Medtronic

- Roche

- Animas Corporation and

- Tandem Diabetes Care

Key Topics Covered:

1. Executive Summary

2. United States Diabetes Population (2011 - 2022): An Analysis

3. United States Insulin Pump Market Analysis (2011- 2022)

4. Key Drivers and Inhibitors of the United States Insulin Pump Market

5. United States Insulin Pump Preferred Brand - By Product

6. United States Insulin Pump Market: Reimbursement & Regulation System

7. United States Insulin Pump Market - Major Deal Types

8. Insulin Pump Market Clinical Trail Insight by Phase, Company & Country

9. Key Companies Analysis

For more information about this report visit https://www.researchandmarkets.com/research/8f5wn4/united_states

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices , Infusions and Injectables

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices , Infusions and Injectables